297 related articles for article (PubMed ID: 18323411)
1. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
[TBL] [Abstract][Full Text] [Related]
2. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
Ko KH; Holmes T; Palladinetti P; Song E; Nordon R; O'Brien TA; Dolnikov A
Stem Cells; 2011 Jan; 29(1):108-18. PubMed ID: 20960517
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
4. GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells.
Dolnikov A; Xu N; Shen S; Song E; Holmes T; Klamer G; O'Brien TA
Cell Prolif; 2014 Apr; 47(2):113-23. PubMed ID: 24517125
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice.
Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A
Stem Cells Dev; 2015 Mar; 24(6):724-36. PubMed ID: 25329250
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
8. GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice.
Shen S; Klamer G; Xu N; O'Brien TA; Dolnikov A
Exp Hematol; 2013 Dec; 41(12):1016-27.e1. PubMed ID: 24018603
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cells.
Jiang J; Zhao M; Zhang A; Yu M; Lin X; Wu M; Wang X; Lu H; Zhu S; Yu Y; Mao Z; Han W
Biomed Pharmacother; 2010 Sep; 64(7):482-6. PubMed ID: 20359857
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.
Kroon J; in 't Veld LS; Buijs JT; Cheung H; van der Horst G; van der Pluijm G
Oncotarget; 2014 Oct; 5(19):8986-94. PubMed ID: 25344861
[TBL] [Abstract][Full Text] [Related]
13. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of glycogen synthase kinase-3β up-regulates β-catenin and promotes chondrogenesis.
Zhou J; Chen Y; Cao C; Chen X; Gao W; Zhang L
Cell Tissue Bank; 2015 Mar; 16(1):135-42. PubMed ID: 24760579
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
Soda M; Willert K; Kaushansky K; Geddis AE
Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
[TBL] [Abstract][Full Text] [Related]
17. Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.
Duinhouwer LE; Tüysüz N; Rombouts EW; Ter Borg MN; Mastrobattista E; Spanholtz J; Cornelissen JJ; Ten Berge D; Braakman E
PLoS One; 2015; 10(3):e0119086. PubMed ID: 25807521
[TBL] [Abstract][Full Text] [Related]
18. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
Cao Q; Feng YJ
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
20. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
